Gonidas, Christos
Poutahidis, Theofilos
Siasiaridis, Athanasios
Anestakis, Doxakis
Konstantinidou, Polyanthi
Tsingotjidou, Anastasia
Gargani, Sofia
Mosialos, George
Funding for this research was provided by:
Greek State Scholarships Foundation (MIS-5000432)
Article History
Received: 3 April 2025
Accepted: 17 June 2025
First Online: 2 July 2025
Declarations
:
: Mice experiments were approved by the Department of Animal Health & Veterinary Perception, Pharmaceuticals and Applications of the Veterinary Administration of the Region of Central Macedonia (License No. 137941/861/12-04-2018) and conducted at the Laboratory of Anatomy, Histology, and Embryology, School of Veterinary Medicine, Faculty of Health Sciences, AUTH, in the facility utilized for experimentations in mice with severe combined immunodeficiency (facility code number: EL-54-BIOexp-23). All husbandry and experimental procedures were approved by the institutional ethics committee complying with the EU Directive 2010/63/EU.
: The authors declare no competing interests.